Sichenzia Ross Ference Carmel LLP Represents TruGolf, Inc. as Special Securities Counsel in Business Combination with Deep Medicine Acquisition Corp.
Press Release – New York, NY – February 6th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented TruGolf, Inc. (NASDAQ: TRUG) (“TruGolf” or the “Company”) as special securities counsel in the successful completion of its previously announced business combination with Deep Medicine Acquisition Corp. (“Deep Medicine”). The combination has resulted in TruGolf becoming a publicly-traded company, and the combined public company being renamed “TruGolf Holdings, Inc.”
The common stock of the combined company began trading on the NASDAQ Stock Market (“NASDAQ”) under the new ticker symbol “TRUG” on February 1st, 2024.
“We share TruGolf’s vision of making golf more accessible to a broader and rapidly growing audience,” stated Humphrey Polanen, CEO of DMAQ. “TruGolf’s innovative software and data analytics can improve the players’ skills, while the user-friendly design increases their enjoyment of golf.”
Chris Jones, CEO and Co-Founder of TruGolf, commented, “Today marks a significant milestone as we embark on our journey as a publicly traded company. This is not just a financial achievement, as this will serve as a vehicle to accelerate our growth and a testament to the commitment and expertise of our board, management team and passionate employees. We are thankful for the DMAQ team’s support and guidance throughout the transaction process.”
TruGolf is a sporting company focused on the development of ultra-realistic and precise golf simulators and solutions surrounding golf. Their team has built multiple award-winning video games (“Links”), as well as the hardware solutions to accompany such. They’re passionate about the development of innovative indoor golf solutions and helping the golf industry grow by making golf more accessible, affordable, and available.
Deep Medicine was a special purpose acquisition company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. Deep Medicines began trading on the NASDAQ in October 2024 under the ticker “DMAQ” and “DMAQR”, respectively.
The Sichenzia Ross Ference Carmel LLP team was led by partners Arthur Marcus and Matt Siracusa, and law clerk Rohini Sud.
Click here for a full list of recent combinations & transactions headed by SRFC.
This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.
Visit SRFC's LinkedIn page
